Ruby Gupta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ruby Gupta has a total of 245 co-authors. Here are the top co-authors by number of shared publications:
- Dorairaj Prabhakaran
Centre for Chronic Disease Control
39 shared publications - Kolli Srinath Reddy
Public Health Foundation of India
15 shared publications - Nikhil Tandon
Department of Endocrinology and Metabolism All India Institute of Medical Sciences New Delhi India
11 shared publications - Mohammed Kumail Ali
Hubert Department of Global Health Emory University Rollins School of Public Health Atlanta Georgia USA
10 shared publications - Lakshmy Ramakrishnan
Department of Cardiac Biochemistry, All India Institute of Medical Sciences, New Delhi, India
9 shared publications Nikhil Tandon
Departmentof Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India
9 shared publications
Latest Publications
- Open Access
- 14 October 2025
- Published by Taylor & Francis in Global Health Action
- Vol. 18 (1) , 2570600
Does health insurance coverage improve cardiometabolic risk factor levels? Quasi-experimental evidence from India
Chronic conditions cause notable health and economic burdens. While health insurance enables access to healthcare, its effects on chronic care outcomes remain under-explored. To examine the association between health insurance coverage and cardiometabolic risk factors among people with chronic conditions in India. Data from the Centre for Cardiometabolic Risk Reduction in South Asia (CARRS) and Solan studies, including 2,926 adults with chronic conditions were analyzed using propensity score weighting to evaluate the associations between health insurance and cardiometabolic risk factors (HbA1c, low-density lipoprotein cholesterol [LDLc], and blood pressure [BP]) and self-reported health status (measured using European Quality of Life Visual Analogue Scale [EQ-VAS]). Mediation analysis evaluated healthcare visits as a potential mediator. Among 2,926 respondents meeting criteria, mean (SD) age was 54.6 years (11.8), and 1630 (55.7%) were women. Health insurance coverage was low (6.5%) and more prevalent among men, higher-income groups, and rural vs urban residents. Insured participants had lower mean diastolic BP (84.8 vs 86.0 mmHg), mean LDLc (113.3 vs 117.2 mg/dl), mean HbA1c (6.9% vs 7.5%), and higher health status (EQ-VAS: 74.6 vs 69.1) than uninsured participants, respectively (p < 0.05). Mediation analysis showed healthcare visits strongly mediated the relationship between insurance and BP and partially mediated effects on LDLc, HbA1c, and self-rated health. Health insurance coverage was associated with better cardiometabolic risk profiles and health status, largely mediated by increased healthcare utilization. Expanding insurance coverage to include outpatient chronic care services should be prioritized to improve health outcomes in low- and middle-income countries.
- 14 October 2025
- Published by Taylor & Francis in Global Health Action
- Vol. 18 (1) , 2570600
Open AccessDoes health insurance coverage improve cardiometabolic risk factor levels? Quasi-experimental evidence from India
Chronic conditions cause notable health and economic burdens. While health insurance enables access to healthcare, its effects on chronic care outcomes remain under-explored. To examine the association between health insurance coverage and cardiometabolic risk factors among people with chronic conditions in India. Data from the Centre for Cardiometabolic Risk Reduction in South Asia (CARRS) and Solan studies, including 2,926 adults with chronic conditions were analyzed using propensity score weighting to evaluate the associations between health insurance and cardiometabolic risk factors (HbA1c, low-density lipoprotein cholesterol [LDLc], and blood pressure [BP]) and self-reported health status (measured using European Quality of Life Visual Analogue Scale [EQ-VAS]). Mediation analysis evaluated healthcare visits as a potential mediator. Among 2,926 respondents meeting criteria, mean (SD) age was 54.6 years (11.8), and 1630 (55.7%) were women. Health insurance coverage was low (6.5%) and more prevalent among men, higher-income groups, and rural vs urban residents. Insured participants had lower mean diastolic BP (84.8 vs 86.0 mmHg), mean LDLc (113.3 vs 117.2 mg/dl), mean HbA1c (6.9% vs 7.5%), and higher health status (EQ-VAS: 74.6 vs 69.1) than uninsured participants, respectively (p < 0.05). Mediation analysis showed healthcare visits strongly mediated the relationship between insurance and BP and partially mediated effects on LDLc, HbA1c, and self-rated health. Health insurance coverage was associated with better cardiometabolic risk profiles and health status, largely mediated by increased healthcare utilization. Expanding insurance coverage to include outpatient chronic care services should be prioritized to improve health outcomes in low- and middle-income countries.
- 10 October 2025
- Published by Elsevier in The Journal of Nutrition
- Vol. 155 (12) , 4401-4407
Dietary Iodine Intake in Urban and Rural North India: Implications for and Compatibility with Salt Reduction Efforts
- 10 October 2025
- Published by Elsevier in The Journal of Nutrition
- Vol. 155 (12) , 4401-4407
Dietary Iodine Intake in Urban and Rural North India: Implications for and Compatibility with Salt Reduction Efforts
- Open Access
Dietary Iodine Intake in Urban and Rural North India: Implications for and Compatibility with Salt Reduction Efforts
Objective: The World Health Organization (WHO) recommends reducing dietary salt intake to <5gm/d as a cost-effective strategy to reduce hypertension and associated cardiovascular diseases. However, salt is also used as a vehicle for iodine supplementation for preventing iodine deficiency disorders (IDD). Concerns have been expressed that reducing population salt intake will adversely impact iodine levels. Therefore, the aim of this paper was to estimate the daily salt and iodine consumption levels of the adult population in India and examine the effect of the WHO recommended salt intake levels on iodine levels. Methods: A cross-sectional study was conducted in Delhi and Haryana, India among adults aged ≥20 years and 24-hr urine samples were collected to assess the salt and iodine levels . Findings: The mean salt intake was 8.07 gm/d (95% CI: 7.03-9.11), mean urinary iodine concentration (UIC) was 208.90 µg/L (184.53-233.27), and the mean urinary iodine excretion (UIE) was 276.15 µg/24hr (239.68-312.62). Analysis to assess iodine intake adequacy by salt intake levels indicated that the mean UIC [180.35 µg/L (159.49-201.20), as well as UIE [153.67 µg/24hr (127.51-179.83)], were adequate, when salt intake was as per the WHO recommended level i.e., ≤5gm/d. Conclusion: Even at the WHO recommended salt intake levels, population iodine intake in this study population was adequate, likely indicating that upward titration in iodine concentration in salt may not be required. Thus, current salt reduction recommendations are unlikely to impact iodine supplementation efforts, indicating compatibility between the two interventions, which should be continiously monitored through robust surveillance.
Open AccessDietary Iodine Intake in Urban and Rural North India: Implications for and Compatibility with Salt Reduction Efforts
Objective: The World Health Organization (WHO) recommends reducing dietary salt intake to <5gm/d as a cost-effective strategy to reduce hypertension and associated cardiovascular diseases. However, salt is also used as a vehicle for iodine supplementation for preventing iodine deficiency disorders (IDD). Concerns have been expressed that reducing population salt intake will adversely impact iodine levels. Therefore, the aim of this paper was to estimate the daily salt and iodine consumption levels of the adult population in India and examine the effect of the WHO recommended salt intake levels on iodine levels. Methods: A cross-sectional study was conducted in Delhi and Haryana, India among adults aged ≥20 years and 24-hr urine samples were collected to assess the salt and iodine levels . Findings: The mean salt intake was 8.07 gm/d (95% CI: 7.03-9.11), mean urinary iodine concentration (UIC) was 208.90 µg/L (184.53-233.27), and the mean urinary iodine excretion (UIE) was 276.15 µg/24hr (239.68-312.62). Analysis to assess iodine intake adequacy by salt intake levels indicated that the mean UIC [180.35 µg/L (159.49-201.20), as well as UIE [153.67 µg/24hr (127.51-179.83)], were adequate, when salt intake was as per the WHO recommended level i.e., ≤5gm/d. Conclusion: Even at the WHO recommended salt intake levels, population iodine intake in this study population was adequate, likely indicating that upward titration in iodine concentration in salt may not be required. Thus, current salt reduction recommendations are unlikely to impact iodine supplementation efforts, indicating compatibility between the two interventions, which should be continiously monitored through robust surveillance.
- Open Access
Health effects of selected environmental Exposomes Across the Life courSe in Indian populations using longitudinal cohort studies: GEOHealth HEALS Study protocol
Introduction: Air pollution presents a major public health threat to India, affecting more than three quarters of the country’s population. In the current project, GEOHealth Health Effects of Selected Environmental Exposomes Across the Life CourSe–India, we aim to study the effect of environmental exposomes—fine particulate matter (PM 2.5 ), nitrogen dioxide (NO 2 ), ozone (O 3 ) and extremes of temperature—on multiple health outcomes using a modified life course approach. The associated training grant aims to build capacity in India to address the unique environmental health problems. Methods and analysis: The project aims to (A) Develop exposure assessments in seven cities, namely Delhi, Chennai, Sonipat, Vizag, Pune, Hyderabad and Bikaner, for: (1) A fine-scale spatiotemporal model for multiple pollutants (PM 2.5 , NO 2 , O 3, temperature); (2) Combined ground monitoring and modelling for major chemical species of ambient PM 2.5 at seven cities; and (3) Personal exposure assessment in a subsample from the six cities, except Pune, and (B) Conduct health association studies covering a range of chronic non-communicable diseases and their risk factors leveraging a unique approach using interdigitating cohorts. We have assembled existing pregnancy, child, adolescent, adult and older adult cohorts across India to explore health effects of exposomes using causal analyses. We propose to use Bayesian kernel machine regression to assess the effects of mixtures of all pollutants including species of PM 2.5 on health while accounting for potential non-linearities and interactions between exposures. This builds on earlier work that constructed a fine spatiotemporal model for PM 2.5 exposure to study health outcomes in two Indian cities. Ethics and dissemination: Ethical clearance for conduct of the study was obtained from the Institutional Ethics Committee (IEC) of the Centre for Chronic Disease Control, and all the participating institutes and organisations. National-level permission was provided by the Indian Council of Medical Research. The research findings will be disseminated through peer-reviewed publications, policy briefs, print and social media, and communicating with the participating communities and stakeholders. Training of Indian scientists will build the capacity to undertake research on selected adverse environmental exposures on population health in India.
Open AccessHealth effects of selected environmental Exposomes Across the Life courSe in Indian populations using longitudinal cohort studies: GEOHealth HEALS Study protocol
Introduction: Air pollution presents a major public health threat to India, affecting more than three quarters of the country’s population. In the current project, GEOHealth Health Effects of Selected Environmental Exposomes Across the Life CourSe–India, we aim to study the effect of environmental exposomes—fine particulate matter (PM 2.5 ), nitrogen dioxide (NO 2 ), ozone (O 3 ) and extremes of temperature—on multiple health outcomes using a modified life course approach. The associated training grant aims to build capacity in India to address the unique environmental health problems. Methods and analysis: The project aims to (A) Develop exposure assessments in seven cities, namely Delhi, Chennai, Sonipat, Vizag, Pune, Hyderabad and Bikaner, for: (1) A fine-scale spatiotemporal model for multiple pollutants (PM 2.5 , NO 2 , O 3, temperature); (2) Combined ground monitoring and modelling for major chemical species of ambient PM 2.5 at seven cities; and (3) Personal exposure assessment in a subsample from the six cities, except Pune, and (B) Conduct health association studies covering a range of chronic non-communicable diseases and their risk factors leveraging a unique approach using interdigitating cohorts. We have assembled existing pregnancy, child, adolescent, adult and older adult cohorts across India to explore health effects of exposomes using causal analyses. We propose to use Bayesian kernel machine regression to assess the effects of mixtures of all pollutants including species of PM 2.5 on health while accounting for potential non-linearities and interactions between exposures. This builds on earlier work that constructed a fine spatiotemporal model for PM 2.5 exposure to study health outcomes in two Indian cities. Ethics and dissemination: Ethical clearance for conduct of the study was obtained from the Institutional Ethics Committee (IEC) of the Centre for Chronic Disease Control, and all the participating institutes and organisations. National-level permission was provided by the Indian Council of Medical Research. The research findings will be disseminated through peer-reviewed publications, policy briefs, print and social media, and communicating with the participating communities and stakeholders. Training of Indian scientists will build the capacity to undertake research on selected adverse environmental exposures on population health in India.
- Open Access
- 6 April 2024
- Published by MDPI AG in Metabolites
- Vol. 14 (4) , 208
Pancreatic Beta Cell Function in Infants Varies by Maternal Weight
The Asian Indian Beta Cell function (ABCs) in Infants Study examined the associations of maternal weight on infant pancreatic beta cell function across 7 months postpartum. Pregnant women aged 18–35 years were recruited in Hyderabad, India. Women were classified by first trimester weight as underweight (UW), BMI < 18.5 kg/m2; normal weight (NW), BMI 18.5–22.9 kg/m2; or overweight (OW), BMI 23.0 through 7 months, infants had an oral glucose tolerance test (OGTT, 1.75 g glucose/kg bodyweight) following a 3 h fast. Infant blood samples were assayed for C-peptide and glucose. Infant beta cell function (HOMA2-B; disposition index, DI) and insulin resistance (HOMA2-IR) were compared across maternal weight groups. Mothers (UW n = 63; NW n = 43; OW n = 29) had similar age at delivery and second trimester 50 g glucose challenge test results. Cord HOMA2-B values were 51% greater for IUW (83.5, SD 55.2) and 44% greater for IOW (79.9, SD 60.8) vs. INW (55.4, SD 51.5), forming a U-shaped relationship between maternal weight and HOMA2-B. No qualitative differences in HOMA2-IR were found at birth. However, at 7 months postpartum, HOMA2-IR changed most within IUW (−64% median reduction) and changed the least in IOW (−7% median reduction). At seven months postpartum, DI was higher in IUW vs. the other groups (geometric mean IUW 1.9 SD 2.5; INW 1.3 SD 2.6 or vs. IOW mean 1.2 SD 3.7), reflecting a +49% difference in DI. Evidence from this study illustrates adaptations in the pancreatic functional response of infants associated with the maternal nutritional environment.
- 6 April 2024
- Published by MDPI AG in Metabolites
- Vol. 14 (4) , 208
Open AccessPancreatic Beta Cell Function in Infants Varies by Maternal Weight
The Asian Indian Beta Cell function (ABCs) in Infants Study examined the associations of maternal weight on infant pancreatic beta cell function across 7 months postpartum. Pregnant women aged 18–35 years were recruited in Hyderabad, India. Women were classified by first trimester weight as underweight (UW), BMI < 18.5 kg/m2; normal weight (NW), BMI 18.5–22.9 kg/m2; or overweight (OW), BMI 23.0 through 7 months, infants had an oral glucose tolerance test (OGTT, 1.75 g glucose/kg bodyweight) following a 3 h fast. Infant blood samples were assayed for C-peptide and glucose. Infant beta cell function (HOMA2-B; disposition index, DI) and insulin resistance (HOMA2-IR) were compared across maternal weight groups. Mothers (UW n = 63; NW n = 43; OW n = 29) had similar age at delivery and second trimester 50 g glucose challenge test results. Cord HOMA2-B values were 51% greater for IUW (83.5, SD 55.2) and 44% greater for IOW (79.9, SD 60.8) vs. INW (55.4, SD 51.5), forming a U-shaped relationship between maternal weight and HOMA2-B. No qualitative differences in HOMA2-IR were found at birth. However, at 7 months postpartum, HOMA2-IR changed most within IUW (−64% median reduction) and changed the least in IOW (−7% median reduction). At seven months postpartum, DI was higher in IUW vs. the other groups (geometric mean IUW 1.9 SD 2.5; INW 1.3 SD 2.6 or vs. IOW mean 1.2 SD 3.7), reflecting a +49% difference in DI. Evidence from this study illustrates adaptations in the pancreatic functional response of infants associated with the maternal nutritional environment.
- 5 February 2024
- Published by Springer Nature in Acta Diabetologica
- Vol. 61 (5) , 577-586
Association of pro-inflammatory cytokines, adipokines and hepatokine with incident diabetes in India: a nested case–control study within CARRS cohort
Aims To study the association of pro-inflammatory markers with incident diabetes in India. Methods We did a nested case–control study within the CARRS (Centre for Ardiometabolic Risk Reduction in South Asia) cohort. Of the 5739 diabetes-free individuals at the baseline, 216 participants with incident diabetes and 432 age-, gender- and city-matched controls at 2-year follow-up were included. We measured high sensitive C-reactive protein (hsCRP), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 ( MCP-1), adiponectin, leptin and fetuin-A in the stored baseline blood samples. We did multivariate conditional logistic regression to estimate association of inflammatory markers (as quartiles) and incident diabetes. Covariates were baseline fasting plasma glucose (FPG) and lipids, body mass index (BMI), family history of diabetes, smoking and alcohol use. Results Baseline hsCRP and TNF-α were higher, and IL-6 and adiponectin were lower among cases vs. controls. In multivariate conditional logistic regression models, only quartile-3 (odds ratio [OR]: 2.96 [95% CI:1.39, 6.30]) and quartile-4 (OR: 2.58 [95% CI: 1.15, 5.79]) of TNF-α and quartile-4 of MCP-1 (OR: 2.55 [95% CI: 1.06, 6.16]) were positively associated with diabetes after adjusting for baseline FPG and BMI. These associations did not remain after adjusting for family history. High level (quartile-4) of IL-6 was negatively associated with diabetes after adjusting for all factors (OR: 0.18 [95% CI: 0.06, 0.55]). Conclusions Higher TNF-α and MCP-1 levels and lower IL-6 were associated with higher risk of developing diabetes. Better understanding and potential methods of addressing these biomarkers, especially in relation to family history, are needed to address diabetes in South Asians.
- 5 February 2024
- Published by Springer Nature in Acta Diabetologica
- Vol. 61 (5) , 577-586
Association of pro-inflammatory cytokines, adipokines and hepatokine with incident diabetes in India: a nested case–control study within CARRS cohort
Aims To study the association of pro-inflammatory markers with incident diabetes in India. Methods We did a nested case–control study within the CARRS (Centre for Ardiometabolic Risk Reduction in South Asia) cohort. Of the 5739 diabetes-free individuals at the baseline, 216 participants with incident diabetes and 432 age-, gender- and city-matched controls at 2-year follow-up were included. We measured high sensitive C-reactive protein (hsCRP), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 ( MCP-1), adiponectin, leptin and fetuin-A in the stored baseline blood samples. We did multivariate conditional logistic regression to estimate association of inflammatory markers (as quartiles) and incident diabetes. Covariates were baseline fasting plasma glucose (FPG) and lipids, body mass index (BMI), family history of diabetes, smoking and alcohol use. Results Baseline hsCRP and TNF-α were higher, and IL-6 and adiponectin were lower among cases vs. controls. In multivariate conditional logistic regression models, only quartile-3 (odds ratio [OR]: 2.96 [95% CI:1.39, 6.30]) and quartile-4 (OR: 2.58 [95% CI: 1.15, 5.79]) of TNF-α and quartile-4 of MCP-1 (OR: 2.55 [95% CI: 1.06, 6.16]) were positively associated with diabetes after adjusting for baseline FPG and BMI. These associations did not remain after adjusting for family history. High level (quartile-4) of IL-6 was negatively associated with diabetes after adjusting for all factors (OR: 0.18 [95% CI: 0.06, 0.55]). Conclusions Higher TNF-α and MCP-1 levels and lower IL-6 were associated with higher risk of developing diabetes. Better understanding and potential methods of addressing these biomarkers, especially in relation to family history, are needed to address diabetes in South Asians.
- 3 November 2022
- Published by Elsevier in Cancer Epidemiology
- Vol. 81, 102283
Time intervals and patient-level factors in oral cancer diagnostic pathways: An application of the WHO framework in India
- 3 November 2022
- Published by Elsevier in Cancer Epidemiology
- Vol. 81, 102283
Time intervals and patient-level factors in oral cancer diagnostic pathways: An application of the WHO framework in India
- Open Access
- 17 August 2022
- Published by Elsevier in The Lancet Regional Health - Southeast Asia
- Vol. 6, 100062
Estimated glomerular filtration rate trajectories in south Asians: Findings from the cardiometabolic risk reduction in south Asia study
- 17 August 2022
- Published by Elsevier in The Lancet Regional Health - Southeast Asia
- Vol. 6, 100062
Open AccessEstimated glomerular filtration rate trajectories in south Asians: Findings from the cardiometabolic risk reduction in south Asia study
- Open Access
- 2 August 2022
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 17 (1) , 52
Cardiovascular Health in India – a Report Card from Three Urban and Rural Surveys of 22,144 Adults
Background: Markers of ideal cardiovascular health (CVH) predict cardiovascular events. We estimated the prevalence of ideal CVH markers in two levels of cities and villages in India.Methods: We did pooled analysis of individual-level data from three cross sectional surveys of adults ≥ 30 years over 2010–14 (CARRS: Centre for cArdiometabolic Risk Reduction in South Asia; UDAY and Solan Surveillance Study) representing metropolitan cities; smaller cities and rural areas in diverse locations of India. We defined ideal CVH using modified American Heart Association recommendations: not smoking, ≥ 5 servings of fruits and vegetables (F&V), high physical activity (PA), body mass index (BMI) <25 Kg/m2, blood pressure (BP) <120/80 mm Hg, fasting plasma glucose (FPG) <100 mg/dl, and total cholesterol (TC) <200 mg/dL. We estimated (1) age-and sex-standardized prevalence of ideal CVH and (2) prevalence of good (≥6 markers), moderate (4–5), and poor CVH (≤3) adjusted for age, sex, education, and stratified by setting and asset tertiles.Results: Of the total 22,144 participants, the prevalence of ideal CVH markers were: not smoking (76.7% [95% CI 76.1, 77.2]), consumed ≥5 F&V (4.2% [3.9, 4.5]), high PA (67.5% [66.8, 68.2]), optimum BMI (59.6% [58.9, 60.3]), ideal BP (34.5% [33.9, 35.2]), FPG (65.8% [65.1, 66.5]) and TC (65.4% [64.7, 66.1]). The mean number of ideal CVH metrics was 3.7(95% CI: 3.7, 3.8). Adjusted prevalence of good, moderate, and poor CVH, varied across settings: metropolitan (3.9%, 41.0%, and 55.1%), smaller cities (7.8%, 49.2%, and 43%), and rural (10.4%, 60.9%, and 28.7%) and across asset tertiles: Low (11.0%, 55.9%, 33.1%), Middle (6.3%, 52.2%, 41.5%), and High (5.0%, 46.4%, 48.7%), respectively.Conclusion: Achievement of ideal CVH varied, with higher prevalence in rural and lower asset tertiles. Multi-sectoral and targeted policy and program actions are needed to improve CVH in diverse contexts in India. Publisher’s Note: A correction article relating to this paper has been published and can be found at https://globalheartjournal.com/articles/10.5334/gh.1158/.
- 2 August 2022
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 17 (1) , 52
Open AccessCardiovascular Health in India – a Report Card from Three Urban and Rural Surveys of 22,144 Adults
Background: Markers of ideal cardiovascular health (CVH) predict cardiovascular events. We estimated the prevalence of ideal CVH markers in two levels of cities and villages in India.Methods: We did pooled analysis of individual-level data from three cross sectional surveys of adults ≥ 30 years over 2010–14 (CARRS: Centre for cArdiometabolic Risk Reduction in South Asia; UDAY and Solan Surveillance Study) representing metropolitan cities; smaller cities and rural areas in diverse locations of India. We defined ideal CVH using modified American Heart Association recommendations: not smoking, ≥ 5 servings of fruits and vegetables (F&V), high physical activity (PA), body mass index (BMI) <25 Kg/m2, blood pressure (BP) <120/80 mm Hg, fasting plasma glucose (FPG) <100 mg/dl, and total cholesterol (TC) <200 mg/dL. We estimated (1) age-and sex-standardized prevalence of ideal CVH and (2) prevalence of good (≥6 markers), moderate (4–5), and poor CVH (≤3) adjusted for age, sex, education, and stratified by setting and asset tertiles.Results: Of the total 22,144 participants, the prevalence of ideal CVH markers were: not smoking (76.7% [95% CI 76.1, 77.2]), consumed ≥5 F&V (4.2% [3.9, 4.5]), high PA (67.5% [66.8, 68.2]), optimum BMI (59.6% [58.9, 60.3]), ideal BP (34.5% [33.9, 35.2]), FPG (65.8% [65.1, 66.5]) and TC (65.4% [64.7, 66.1]). The mean number of ideal CVH metrics was 3.7(95% CI: 3.7, 3.8). Adjusted prevalence of good, moderate, and poor CVH, varied across settings: metropolitan (3.9%, 41.0%, and 55.1%), smaller cities (7.8%, 49.2%, and 43%), and rural (10.4%, 60.9%, and 28.7%) and across asset tertiles: Low (11.0%, 55.9%, 33.1%), Middle (6.3%, 52.2%, 41.5%), and High (5.0%, 46.4%, 48.7%), respectively.Conclusion: Achievement of ideal CVH varied, with higher prevalence in rural and lower asset tertiles. Multi-sectoral and targeted policy and program actions are needed to improve CVH in diverse contexts in India. Publisher’s Note: A correction article relating to this paper has been published and can be found at https://globalheartjournal.com/articles/10.5334/gh.1158/.
- Open Access
- 11 January 2022
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 17 (1) , 68
Correction: Cardiovascular Health in India – a Report Card from Three Urban and Rural Surveys of 22,144 Adults
This article details a correction to: Shivashankar R, Singh K, Kondal D, Gupta R, Perel P, Kapoor D, et al.. Cardiovascular Health in India – a Report Card from Three Urban and Rural Surveys of 22,144 Adults. Global Heart. 2022; 17(1): 52. DOI: http://doi.org/10.5334/gh.1137
- 11 January 2022
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 17 (1) , 68
Open AccessCorrection: Cardiovascular Health in India – a Report Card from Three Urban and Rural Surveys of 22,144 Adults
This article details a correction to: Shivashankar R, Singh K, Kondal D, Gupta R, Perel P, Kapoor D, et al.. Cardiovascular Health in India – a Report Card from Three Urban and Rural Surveys of 22,144 Adults. Global Heart. 2022; 17(1): 52. DOI: http://doi.org/10.5334/gh.1137